{"url":"https://lda.senate.gov/api/v1/filings/ac2dcd7b-b657-40e2-a193-ae71bbb6c1d5/","filing_uuid":"ac2dcd7b-b657-40e2-a193-ae71bbb6c1d5","filing_type":"RR","filing_type_display":"Registration","filing_year":2008,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ac2dcd7b-b657-40e2-a193-ae71bbb6c1d5/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Lance B. Leggitt, Shareholder","dt_posted":"2008-11-18T11:22:26-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"555 11TH STREET, NW","registrant_address_2":"6TH FLOOR","registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":5153,"url":"https://lda.senate.gov/api/v1/registrants/5153/","house_registrant_id":30873,"name":"BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ","description":"Law firm","address_1":"901 K Street NW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DUANE HANECKOW","contact_telephone":"+1 202-508-3400","dt_updated":"2026-07-17T16:11:23.326015-04:00"},"client":{"id":105667,"url":"https://lda.senate.gov/api/v1/clients/105667/","client_id":1005243,"name":"ACTAVIS, INC.","general_description":"Pharmaceutical","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-10-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Engage with FDA and Congress regarding pharmaceutical and medical manufacturing and regarding regulatory issues.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":36989,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":"L","last_name":"JOHNSON","suffix":null,"suffix_display":null},"covered_position":"Former Member of Congress","new":true},{"lobbyist":{"id":41833,"prefix":null,"prefix_display":null,"first_name":"LANCE","nickname":null,"middle_name":"B","last_name":"LEGGITT","suffix":null,"suffix_display":null},"covered_position":"Spec. Asst. to the President for Domestic Policy","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"ACTAVIS GROUP","contribution":null,"ownership_percentage":"100.00","address":"Dalshrauni 1","city":"220 Hafnarfirdi","state":null,"state_display":null,"country":"IS","country_display":"Iceland","ppb_city":"Dalshrauni 1","ppb_state":null,"ppb_state_display":null,"ppb_country":"IS","ppb_country_display":"Iceland"}],"affiliated_organizations":[]}